Guanine nucleotide-binding protein alpha subunit (Gα) (Gα)

Guanine nucleotide-binding protein alpha subunits (Gα) are essential components of heterotrimeric G-proteins that relay signals from cell-surface G-protein-coupled receptors (GPCRs) to intracellular effectors (StatPearls, 2023). They function as molecular switches, cycling between an inactive GDP-bound state and an active GTP-bound state (UniProt, 2024). The Gα family is divided into four main classes—Gs, Gi/o, Gq/11, and G12/13—which regulate diverse processes such as cAMP production, calcium signaling, and cytoskeletal remodeling (PubMed, 2022). Dysregulation or somatic mutations in Gα genes are linked to various diseases, including uveal melanoma, McCune-Albright syndrome, and certain endocrine tumors (NIH, 2023). While GPCRs have historically been the primary drug targets, direct pharmacological modulation of Gα subunits with small molecules like YM-254890 or bacterial toxins provides a strategy for treating G-protein-driven pathologies (Nature Reviews Drug Discovery, 2021). This approach allows for more precise control over specific signaling branches compared to broad receptor-level modulation.

Other names

G-alpha subunitG protein alpha subunitGTP-binding protein alpha subunitGuanine nucleotide-binding protein alpha

Drugs and toxins targeting G-protein alpha subunits act by modulating the nucleotide binding cycle. For instance, Cholera toxin catalyzes the ADP-ribosylation of Gs alpha, inhibiting its GTPase activity and locking it in a constitutively active state (StatPearls, 2023). Conversely, Pertussis toxin ADP-ribosylates Gi alpha, preventing its interaction with GPCRs and maintaining it in an inactive state (PubMed, 2021). Small molecule inhibitors like YM-254890 specifically block the exchange of GDP for GTP on Gq alpha subunits, effectively silencing downstream signaling (Nature, 2018).